Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
11/2008
11/18/2008US7452870 Drug-eluting stents coated with P2Y12 receptor antagonist compound
11/18/2008US7452698 They are stable at high temperature, used in nucleic acid amplification and analysis, for improved incorporation and direct loading of nucleic acid sequencing reactions onto separating media
11/18/2008US7452674 Detectable labeled nucleoside analogs and methods of use thereof
11/18/2008US7452663 Kits for detection of ATP
11/18/2008CA2413163C 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides
11/18/2008CA2400470C Methods for synthesizing 2-chloro-9-(2-deoxy-2-fluoro-.beta.-d-arabinofuranosyl)-9h-purin-6-amine
11/18/2008CA2338721C New cofactors for methyltransferases
11/14/2008CA2685748A1 Azido purine nucleosides for treatment of viral infections
11/13/2008WO2008121941B1 Prodrugs of triciribine and triciribine phosphate
11/13/2008US20080280850 administering an effective viriuses treatment amount of a base-modified nucleoside or a salt or prodrug for treating a host infected with flavivirus, pestivirus or hepacivirus
11/13/2008US20080280846 2', 3'-dideoxynucleoside analogues for the treatment or prevention of flaviviridae infections
11/13/2008US20080280842 Fluorinated Pyrrolo[2,3-D]Pyrimidine Nucleosides for the Treatment of Rna-Dependent Rna Viral Infection
11/12/2008EP1989214A1 Process for preparing an a2a-adenosine receptor agonist and its polymorphs
11/12/2008EP1989206A2 Inhibitors of e1 activating enzyme
11/12/2008CN101302239A Synthetic method of telbivudine and intermediate thereof
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN100432086C Method of fluorination
11/11/2008US7449570 Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases
11/06/2008WO2008133129A1 Therapeutic agent for glaucoma comprising adenosine a2a receptor agonist as active ingredient
11/06/2008WO2008067002A3 Azole nucleosides and use as inhibitors of rna and dna varial polymerases
11/06/2008WO2008037036A3 Oligonucleotide arrays
11/06/2008US20080274997 Fluid bed granulation process; water soluble grains; solid oral drug
11/06/2008US20080274462 Universal bases for nucleic acid analyses, methods for using universal bases, and kits comprising universal bases
11/05/2008EP1987050A2 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
11/05/2008EP1730307A4 Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry
11/05/2008CN101298464A Photolabile compound, oligomer probe array and substrate, and manufacturing method of the same
11/05/2008CN100430410C Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives
11/04/2008US7446183 Fusion protein comprising growth hormone and growth hormone receptor
11/04/2008US7445902 Fluorescent nucleotide analogues
10/2008
10/30/2008WO2008131062A2 Process for preparing capecitabine
10/30/2008WO2008130902A1 Agonists of a2a adenosine receptors for treating recurrent tumor growth in the liver following resection
10/30/2008WO2008129530A1 Gemcitabine production process
10/30/2008WO2008128686A1 Nucleotide with an alpha-phosphate mimetic
10/30/2008WO2008128428A1 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof
10/30/2008WO2008107771A3 2',3'-di-o-acyl-5-fluoronucleosides
10/30/2008WO2008005542A3 Antiviral phosphinate compounds
10/30/2008WO2007070598A3 Nucleotide and oligonucleotide prodrugs
10/30/2008WO2007070598A2 Nucleotide and oligonucleotide prodrugs
10/30/2008US20080269476 Molecules and methods for nucleic acid sequencing
10/30/2008US20080268542 Fluid mixture for enhancing vector transfection into mammalian cells
10/30/2008US20080268498 Heat resistant polymerase for propagation of preferential nucleotide sequences
10/30/2008CA2684638A1 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof
10/29/2008EP1984382A2 Lna modified phosphorothiolated oligonucleotides
10/29/2008EP1984381A2 6-modified bicyclic nucleic acid analogs
10/29/2008CN101296934A Process for preparing gemcitabine and associated intermediates
10/29/2008CN101293907A Technique for preparing 5í»-inosine acid disodium
10/28/2008US7442788 Nucleosides; peptide nucleic acids; orientation of sugar governs positioning of antisense molecule
10/28/2008US7442506 Methods for detection of genetic disorders
10/23/2008WO2008128193A1 Biodegradable polyanhydrides with natural bioactive molecules
10/23/2008US20080262215 Gemcitabine production process
10/23/2008US20080262214 Synthesis of 2-Substituted Adenosines
10/23/2008US20080261913 Compounds and pharmaceutical compositions for the treatment of liver disorders
10/23/2008US20080261823 Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides
10/23/2008US20080261208 For DNA sequencing
10/22/2008EP1982721A1 Method of stabilizing s-adenosyl-l-methionine and stabilized composition
10/22/2008EP1532177B1 Immunomodulatory constructs and their uses
10/22/2008CN101289455A Anti-influenza virus precursor drug and uses thereof
10/22/2008CN101289449A 2,6-di-nitrogen-containing substituted purine derivatives, preparation method and applications thereof
10/21/2008US7439351 2′ or 3′ -deoxy and 2′, 3′-dideoxy-β-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti-viral agents
10/21/2008US7439350 Chemical intermediates for viricides, antitumor agents, anticarcinogenic agents
10/21/2008US7439349 Method for preparation of large volume batches of poly-ICLC with increased biological potency; therapeutic, clinical and veterinary uses thereof
10/21/2008CA2468847C Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
10/21/2008CA2330974C Energy transfer assay method and reagent
10/16/2008WO2008089394A3 Mycobacterium tuberculosis persistance genes
10/16/2008WO2008082601A3 Compounds and pharmaceutical compositions for the treatment of viral infections
10/16/2008WO2008052722A3 Use of ribavirin-conjugates as an anti-viral drug
10/16/2008WO2007146819A3 Methods for identifying and using snp panels
10/16/2008US20080255063 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF
10/16/2008US20080255005 A two-dimensional matrix for dispersing the probe beads in a thixotropic agent, a scanner, and a spot-picker that isolates the target biomolecule; high throughput assays
10/16/2008US20080253995 For treatment of Flaviviridae infection, including hepatitis C virus, West Nile Virus, yellow fever virus, and rhinovirus infection
10/15/2008EP1576188B1 Methods for using riboprimers for strand displacement replication of target sequences
10/15/2008EP1421094B1 4"-deoxy-4"-(s)-amino avermectin derivatives
10/15/2008EP1296995B1 3'-prodrugs of 2'-deoxy-beta-l-nucleosides
10/15/2008CN101287472A Antiviral 4'-substituted pre-nucleotide phosphoramidates
10/15/2008CN100425620C Technology of extracting adenosin phosphoric acid from date
10/15/2008CN100425619C Method for purifying and preparing nucleoside triphosphate derivative
10/15/2008CN100425618C Method for separating 5' nucleoside triphosphate continuously
10/15/2008CN100425617C Fluoropyrimidine compound carbalkoxylation method
10/14/2008US7435724 Degradation-resistant mononucleoside phosphate compounds
10/09/2008WO2008121941A1 Prodrugs of triciribine and triciribine phosphate
10/09/2008WO2008119181A1 Stabilized gold nanoparticles and methods of making the same
10/09/2008US20080249060 Nucleoside derivatives for treating hepatitis c virus infection
10/09/2008US20080248012 Modulator of adenosine triphosphate release from red blood cells; treating and preventing ischemic reperfusion injuries, cardiovascular and vasodilatory diseases
10/09/2008CA2682513A1 Stabilized gold nanoparticles and methods of making and using the same
10/09/2008CA2682230A1 Nucleoside phosphoramidate prodrugs
10/08/2008EP1978110A1 System, method and apparatus for transgenic and targeted mutagenesis screening
10/08/2008EP1978095A1 Chimeric receptor proteins for controlling signal transduction and ligands binding thereto
10/08/2008EP1976382A2 Process for preparing a synthetic intermediate for preparation of branched nucleosides
10/08/2008CN101279994A Halogenated nucleosides drug ester derivates and preparation thereof
10/08/2008CN100424091C Method for purifying protected 2'-deoxycytidines
10/07/2008US7432368 Photolabile protecting groups
10/07/2008US7432272 Pharmacokinetic properties, including improved oral bioavailability, greater potency and extended effective drug biological half-life in vivo; inhibiting RNA-dependent RNA polymerase, infections
10/07/2008US7432253 Phosphoepoxides, method for making same and uses
10/07/2008US7432252 Method of promoting cervical and vaginal secretions
10/07/2008US7432248 6-Oxyamino-7-deazapurin-9-yl-2-substituted ribofuranose derivatives, e.g., 1-(6-hydroxylamino-7-ethenyl-7-deazapurin-9-yl)-2-methyl- beta -D-ribofuranose; treating viral infections mediated by a virus in the flaviviridae family
10/07/2008US7432246 Sir2 products and activities
10/07/2008US7432058 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor;
10/07/2008CA2444071C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
10/07/2008CA2277198C Stabilized aqueous nucleoside triphosphate solution
10/02/2008WO2008042067A3 Compositions and methods for nucleotide sequencing
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 201